gliclazide has been researched along with Renal Insufficiency, Chronic in 2 studies
Gliclazide: An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.
Renal Insufficiency, Chronic: Conditions in which the KIDNEYS perform below the normal level for more than three months. Chronic kidney insufficiency is classified by five stages according to the decline in GLOMERULAR FILTRATION RATE and the degree of kidney damage (as measured by the level of PROTEINURIA). The most severe form is the end-stage renal disease (CHRONIC KIDNEY FAILURE). (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mifsud, S | 1 |
| Schembri, EL | 1 |
| Fava, S | 1 |
| Morieri, ML | 1 |
| Vitturi, N | 1 |
| Avogaro, A | 1 |
| Targher, G | 1 |
| Fadini, GP | 1 |
2 other studies available for gliclazide and Renal Insufficiency, Chronic
| Article | Year |
|---|---|
A case of severe relapsing sulphonylurea-induced hypoglycaemia.
Topics: Diabetes Mellitus, Type 2; Female; Gliclazide; Humans; Hypoglycemia; Middle Aged; Renal Insufficienc | 2019 |
Prevalence of hepatic steatosis in patients with type 2 diabetes and response to glucose-lowering treatments. A multicenter retrospective study in Italian specialist care.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Diabetes Mellitus, Type 2; Fatty Liver; Female; Follow-U | 2021 |